miércoles, 6 de noviembre de 2024
The Lancet Oncology Commission on radiotherapy and theranostics Nov 12, 2024 13:30 GMT / 08:30 EST
https://www.thelancet.com/webinars?dgcid=hubspot_email_update_feature_lancetwebinars_landia&utm_campaign=update-landia&utm_medium=email&_hsenc=p2ANqtz--cgRVEkDNahR0EDm7XQwPHbS8UHOtfqsAWSc7sYArdRwJGNsSBjF9yMv49amy5Z-FOHuGuOVY3VCWTQjtDzckXDGDXSA&_hsmi=332481249&utm_content=332425111&utm_source=hs_email
The Lancet Oncology Commission on radiotherapy and theranostics aims to assess the current state of access and availability of radiotherapy and address the important issue of global access to the promising field of theranostics. During this Lancet Webinar, our Commission authors will discuss action points and investment that could enhance access to radiotherapy and theranostics, particularly in low-income and middle-income countries, to realise health and economic benefits and reduce the global burden of cancer.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario